Home›Five systems›Dog Oral Care System

Priority system 3 · Validate before scale

Private-label dog oral care system

Aimo coordinates dog toothpaste, dental-gel and dental-finger-wipe development as an oral-care system. This category is promoted only after oral-contact ingredient review, palatability direction, packaging compatibility and the exact test plan are approved. A consumer toothpaste formula must not be assumed suitable for dogs.

Submit a project brief See decision specification

Verified role statedEvidence gateNon-medicated laneMOQ boundariesLast verified 2 September 2026

Direct procurement answer

What can a buyer rely on today?

Guangzhou Aimo Pet Products Co., Ltd. is the public brand, commercial and export counterparty. Development offer. No finished oral-care formula, fixed MOQ, test result or producing-site capability is represented as verified until the project evidence gate clears.

This wording deliberately separates a commercial offer from a factory certificate, completed audit, test result or regulatory approval.

Concept presentation for Dog Oral Care System private-label project

Project architecture

Offer: dog toothpaste or dental gel + dental finger wipes + coordinated kit.

Best-fit buyers: pet-wellness brands, retailers, DTC brands and distributors.

MOQ rule: Quoted only after formula type, flavour, tube/jar, fill weight, wipe format and printed component minimums are confirmed.

Sample rule: A development sample begins after a written oral-contact brief and ingredient exclusion list; timing and iterations are confirmed in the sample plan.

Specify the format before asking for a quote

Format	Procurement definition
Dog toothpaste	Paste rheology, palatability, flavour and tube compatibility are developed together.
Dental gel	Lower-viscosity leave-on direction; application method and permitted claims require review.
Dental finger wipe	Oral-contact lotion, seam strength, finger fit and single-use instructions are specified separately.
Oral-care kit	Paste or gel and wipes can share brand architecture after both formats pass their own approval gates.

Claims boundary

Xylitol is excluded from the proposed dog oral-care direction.
No human toothpaste base is relabelled for dogs without a fresh safety review.
No plaque, gingivitis, periodontal, antibacterial or veterinary treatment claim without market-specific substantiation.

Evidence pack required before production approval

01 · Full formula and oral-contact safety review

Confirm subject, issuer/owner, method or scope, date, limitations and whether the item is safe to disclose.

02 · Xylitol/fluoride and flavour declaration

Confirm subject, issuer/owner, method or scope, date, limitations and whether the item is safe to disclose.

03 · Palatability/use assessment plan

Confirm subject, issuer/owner, method or scope, date, limitations and whether the item is safe to disclose.

04 · Microbiology, challenge and stability

Confirm subject, issuer/owner, method or scope, date, limitations and whether the item is safe to disclose.

05 · Tube/jar/wipe-pack compatibility

Confirm subject, issuer/owner, method or scope, date, limitations and whether the item is safe to disclose.

06 · Producing entity and line scope

Confirm subject, issuer/owner, method or scope, date, limitations and whether the item is safe to disclose.

A buyer can review the cross-category status matrix in Aimo’s five-product OEM readiness room. A company statement is not the same as an independent certificate or test report.

Buyer questions, answered without overclaiming

Does Aimo have a finished dog toothpaste formula?

The public offer is a development program, not proof of a finished tested formula. The exact formula and producer must be evidenced before quotation approval.

Is the product xylitol-free?

The proposed dog oral-care direction excludes xylitol, but the final signed formula and raw-material declarations are the controlling evidence.

What about fluoride?

Fluoride use is not assumed. The final ingredient policy must be approved for the intended use, instructions and target market.

Can toothpaste and dental wipes be one project?

Yes as a coordinated development and sourcing project, but each format has a separate producer/line, ingredient, stability and packaging evidence gate.

What claims are unsafe to assume?

Plaque removal, gingivitis prevention, antibacterial action, periodontal treatment and veterinary efficacy require evidence and market-specific legal review.

What determines MOQ and lead time?

Formula batch, flavour, tube or jar components, decoration, fill weight, wipe packaging and testing. A fixed number before those variables are approved would be misleading.

Project intake

Send the variables that control feasibility and MOQ

Include target market, product form, annual volume, reference SKU, formula/claim direction, pack size, closure, decoration and desired launch date. Aimo will return a question list and evidence plan before presenting an unsupported factory promise.

alex@aimopet.com
+86-150-1420-2977